C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Director of Oculoplastics and Orbital Surgery, Yale University, discusses referral of patients with thyroid eye disease. Summary: The three…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses artificial corneas or keratoprostheses and compares results to corneal transplantation using a human…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses lasik surgery and long-term data showing prior lasik eye surgery affects measurements following…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of Ocular Oncology Section Yale University School of Medicine, describes uveal melanoma, a rare cancer but the most common cause…
Gary Falk, MD, MS, Professor of Medicine, Director, Center for Esophageal and Swallowing Disorders, Cleveland Clinic, discusses Barrett’s esophagus and its identification and treatment in the primary care…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitor gefitinib is more effective than standard therapy with carboplatin-paclitaxel for lung adenocarcinomas with mutations in the epidermal growth factor…
NEW YORK (Reuters Health) – Roughly 56% of melanomas detected in general dermatology practice are found through full-body skin examinations (FBSE), not as the result of patient complaint,…
NEW YORK (Reuters Health) – In children in the ER, use of ketamine at a high IV dose increases the risks of airway and respiratory events, emesis, and…
NEW YORK (Reuters Health) – The use of ACE inhibitors prior to coronary artery bypass grafting (CABG) is associated with an increased risk of death, need for inotropic…
NEW YORK (Reuters Health) – Five-year survival is similar whether patients with acute MI are treated with primary percutaneous coronary intervention (PCI) or pre-hospital lysis followed by transfer…
